Active

Trim Therapeutics

Switched

BE1011963287

Rechtspersoon Public limited company 1 establishment

Pieter van Reysschootlaan 2/104, 9051 Gent Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

2 year, 1 month

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -627,329

Profit

Caution

€ -2.9 million

Debts

High

€ 4.3 million

Trim Therapeutics from Gent, company number BE1011963287, closed financial year 2025 with a result of € -2.9 million after tax. For that financial year Trim Therapeutics recorded a gross margin of € -627,329 and equity of € -2.8 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 27, 2026.

What happened at Trim Therapeutics?

What happened at Trim Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Katja Rosenkranz stepped down as director. NBB
  • Bart Geers stepped down as director. NBB
  • Willem Frans Broekaert stepped down as director. NBB
  • Jérôme Laurent Van Biervliet stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 2.9 million. Source: NBB ↗
  • New establishment in Gent. KBO
  • Katja Rosenkranz became a director. NBB
  • Bart Geers became a director. NBB

A new publication or filing at Trim Therapeutics? We notify you, reason included.

Follow Trim Therapeutics

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

Katja Rosenkranz

Director

since 2024 · until 2030

Bart Geers

Director

since 2024 · until 2030

Willem Frans Broekaert

Director

since 2024 · until 2030

Jérôme Laurent Van Biervliet

Director

Also active at: Biotope Ventures

since 2024 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Pieter van Reysschootlaan 2/104

9051 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1011.963.287
VAT number
BE 1011.963.287
Registered office
Pieter van Reysschootlaan 2/104, 9051 Gent
Names & denominations
Trim Therapeutics · Trim Tx
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
26 July 2024
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What is the enterprise number of Trim Therapeutics?
The enterprise number of Trim Therapeutics is BE1011963287.
What is the address of Trim Therapeutics?
The registered office of Trim Therapeutics is located at Pieter van Reysschootlaan 2/104, 9051 Gent.
When was Trim Therapeutics founded?
Trim Therapeutics was founded on 26 July 2024.
What is the main activity of Trim Therapeutics?
The main activity of Trim Therapeutics is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does Trim Therapeutics have a website?
No website is currently known for Trim Therapeutics.
How much profit did Trim Therapeutics make in 2025?
Trim Therapeutics recorded a loss after taxes of € 2,915,449 in financial year 2025.
What is the revenue of Trim Therapeutics?
As a small company, Trim Therapeutics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -627,329.
Where can I find the annual accounts of Trim Therapeutics?
Trim Therapeutics files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Trim Therapeutics?
According to the 2025 annual accounts, the directors of Trim Therapeutics are: Katja Rosenkranz, Bart Geers, Willem Frans Broekaert, Jérôme Laurent Van Biervliet.